News and Announcements
Optiscan Imaging – CEO Interview
- Published October 17, 2012 12:54PM UTC
- Publisher Wholesale Investor
- Categories Executive Interviews
Optiscan is a global leader in the development and application of miniaturised microscopic imaging technologies for medical markets. Optiscan’s imaging technology allows live cellular imaging for earlier and better detection of pre-cancerous and cancerous lesions and more accurate resection during surgery. Optiscan’s technology has been incorporated into Pentax endoscopes since 2006 and will soon be incorporated into the product offering of Carl Zeiss Meditec in neurosurgery and ENT surgery.
Executive Interviews
The Democratisation of Private Equity: How $500 Now Buys What Institutions Own
Private equity used to be something that happened over there. Big banks. Big institutions. Deals you read about in the AFR. Now it is entering everyday life. Your mum or dad who has had a business for 30 or 40 years is transitioning that business to private equity. Your favourite sporting team is being assisted […]
What is a Wholesale Investor in Australia? Complete 2026 Guide
What is a Wholesale Investor in Australia? A wholesale investor is an individual or entity that meets specific financial thresholds set out in the Corporations Act 2001 (Cth), qualifying them to access investment opportunities that are not available to general retail investors. These include private equity rounds, venture capital deals, pre-IPO placements, alternative funds, and […]
Why the 20-Year Hold Is the Secret to Australian Life Sciences Returns
Australia represents 0.3% of the world’s population. Yet it generates more than 3% of global research output. Cochlear implants. Wi-Fi. The HPV vaccine. These are not statistical anomalies. They are proof points of a structural advantage that Australia has failed to capitalise on. The country has a world-class research base. But it watches companies scale […]
Backed By Leading Investment Groups and Family Offices
